Overall, even though more studies in humans are required, Lf can be recommended as a promising, completely non-toxic natural adjuvant that can be applied in the long-term prophylaxis and therapy of metabolic disorders such as insulin resistance/type II diabetes and metabolic syndrome. The gene discussed is LTF; the disease is type 2 diabetes mellitus.